Skip to content
Screener

Prelude Therapeutics PRLD Q1 2025 earnings

Reported May 6, 2025 · Before market open

EPS-$0.42Beat by $0.05
EPS estimate-$0.47

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$35.3M
EPS estimate-$0.16

FAQ

When did Prelude Therapeutics report Q1 2025 earnings?
Prelude Therapeutics (PRLD) reported Q1 2025 earnings on May 6, 2025 before market open.
What were Prelude Therapeutics's Q1 2025 revenue and EPS?
Prelude Therapeutics reported eps of $-0.42 for Q1 2025.
Did Prelude Therapeutics beat estimates in Q1 2025?
EPS beat the consensus estimate of $-0.47 by $0.05.
How did Prelude Therapeutics's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 0.0% from $-0.42.
Where can I find Prelude Therapeutics's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-064531) and the 10-Q periodic report (0000950170-25-064566) directly on SEC EDGAR. The filing index links above go to sec.gov.